Diabetes currently effects over 537 million adults worldwide, with obesity-driven Type 2 Diabetes accounting for over 90% of cases.
Dia Beta Labs build on over 30 years of high-impact research from our founding research group at Ulster University to realise the potential of next-generation therapeutics for metabolic disease.
It is our goal to impart significant and much-needed change in the management of the global diabetes/obesity crisis.
Company Details
- Employees
- 4
- Founded
- 2022
- Address
- Coleraine, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://diabetalabs.com
- HQ
- Coleraine
Dia Beta Labs Ltd Questions
Dia Beta Labs Ltd's website is https://diabetalabs.com
Dia Beta Labs Ltd's LinkedIn profile is https://uk.linkedin.com/company/dia-beta-labs-ltd
Dia Beta Labs Ltd has
4 employees.
View email and phone details for 4
employees at Dia Beta Labs Ltd.
Dia Beta Labs Ltd's industry is
Biotechnology Research
Dia Beta Labs Ltd's top competitors are
Klastherapeutics,
Catalyst,
Equipple,
Stimoxygen,
Bdic Medtech,
Talkterms,
Respiratory Analytics,
Cybersyd,
Re-Vana Therapeutics,
E-Breathe.
Dia Beta Labs Ltd's categories are Biotechnology Research
Dia Beta Labs Ltd's founding year is 2022
